• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解成人百日咳的影响和当前的疫苗接种方法:叙述性综述和专家小组建议。

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations.

机构信息

Group Practice & Center, Allergy, Respiratory and Sleep Medicine, Maingau Hospital of the Red Cross, Frankfurt am Main, Germany.

Life and Health Sciences Research Institute, School of Medicine, University of Minho School of Medicine, Braga, Portugal.

出版信息

Hum Vaccin Immunother. 2024 Dec 31;20(1):2324547. doi: 10.1080/21645515.2024.2324547. Epub 2024 Apr 2.

DOI:10.1080/21645515.2024.2324547
PMID:38564339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10989709/
Abstract

Pertussis has several notable consequences, causing economic burden, increased strain on healthcare facilities, and reductions in quality of life. Recent years have seen a trend toward an increase in pertussis cases affecting older children and adults. To boost immunity, and protect vulnerable populations, an enduring approach to vaccination has been proposed, but gaps remain in the evidence surrounding adult vaccination that are needed to inform such a policy. Gaps include: the true incidence of pertussis and its complications in adults; regional variations in disease recognition and reporting; and incidence of severe disease, hospitalizations, and deaths in older adults. Better data on the efficacy/effectiveness of pertussis vaccination in adults, duration of protection, and factors leading to poor vaccine uptake are needed. Addressing the critical evidence gaps will help highlight important areas of unmet need and justify the importance of adult pertussis vaccination to healthcare professionals, policymakers, and payers.

摘要

百日咳有几个显著的后果,导致经济负担加重、医疗设施压力增大以及生活质量下降。近年来,儿童和成人百日咳病例呈上升趋势。为了增强免疫力,保护弱势群体,人们提出了一种持久的疫苗接种方法,但在成人疫苗接种方面,仍存在一些需要的证据空白,以提供这种政策的信息。空白包括:成人百日咳及其并发症的真实发病率;疾病识别和报告的区域差异;以及老年人患重病、住院和死亡的发病率。需要更好的关于成人百日咳疫苗接种的疗效/效果、保护持续时间以及导致疫苗接种率低的因素的数据。解决这些关键的证据空白将有助于突出未满足需求的重要领域,并使医疗保健专业人员、政策制定者和支付方认识到成人百日咳疫苗接种的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6191/10989709/1d764e5da56c/KHVI_A_2324547_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6191/10989709/e36277cd6eec/KHVI_A_2324547_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6191/10989709/2ef34e4209ce/KHVI_A_2324547_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6191/10989709/1d764e5da56c/KHVI_A_2324547_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6191/10989709/e36277cd6eec/KHVI_A_2324547_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6191/10989709/2ef34e4209ce/KHVI_A_2324547_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6191/10989709/1d764e5da56c/KHVI_A_2324547_F0003_OC.jpg

相似文献

1
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations.了解成人百日咳的影响和当前的疫苗接种方法:叙述性综述和专家小组建议。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2324547. doi: 10.1080/21645515.2024.2324547. Epub 2024 Apr 2.
2
Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.破伤风、白喉和无细胞百日咳(Tdap)疫苗在伤口管理中的使用对医疗保健费用和百日咳病例的影响。
J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c. doi: 10.18553/jmcp.2015.21.1.88.
3
The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region.老年人和高危人群中百日咳疫苗接种的需求:来自亚太地区发达经济体的观点。
Expert Rev Vaccines. 2021 Dec;20(12):1603-1617. doi: 10.1080/14760584.2021.1990759. Epub 2021 Nov 22.
4
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
5
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.在治疗阻塞性气道疾病的成年人中,降低抗原破伤风、白喉和无细胞百日咳疫苗的免疫原性和安全性。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2159731. doi: 10.1080/21645515.2022.2159731. Epub 2023 Feb 6.
6
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.关于婴儿百日咳疾病负担及孕妇百日咳免疫效果的系统评价。
Expert Rev Vaccines. 2020 Jul;19(7):621-638. doi: 10.1080/14760584.2020.1791092. Epub 2020 Aug 9.
7
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.美国成年人的破伤风-白喉-无细胞百日咳疫苗接种
Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621.
8
Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis.美国成人(19 岁及以上)中预防百日咳的破伤风、白喉和无细胞百日咳(Tdap)疫苗:成本效益分析。
Prev Med. 2020 May;134:106066. doi: 10.1016/j.ypmed.2020.106066. Epub 2020 Mar 19.
9
Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States.美国实施成人十年破伤风类毒素、减量白喉类毒素和无细胞百日咳(Tdap)疫苗接种的经济影响。
Vaccine. 2020 Jan 10;38(2):380-387. doi: 10.1016/j.vaccine.2019.09.104. Epub 2019 Oct 31.
10
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.无细胞百白破疫苗在风险人群(青少年、孕妇、新生儿和医护人员)中的使用:证据回顾与建议。
Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15.

引用本文的文献

1
Global, regional, and national burdens of pertussis among adults: a systematic analysis of age-specific trends using Global Burden of Diseases 2021 data.成人百日咳的全球、区域和国家负担:利用《2021年全球疾病负担》数据对特定年龄趋势进行的系统分析。
Infect Dis Poverty. 2025 Aug 11;14(1):85. doi: 10.1186/s40249-025-01355-z.
2
Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies.百日咳的再度流行:流行病学趋势、致病机制及预防策略。
Front Immunol. 2025 Jul 10;16:1618883. doi: 10.3389/fimmu.2025.1618883. eCollection 2025.
3
The potential of wastewater monitoring as a novel surveillance tool for early warning of outbreaks.

本文引用的文献

1
Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model.反复感染百日咳博德特氏菌可重塑猴模型中无细胞百日咳疫苗引发的宿主反应。
J Infect Dis. 2024 Feb 14;229(2):376-383. doi: 10.1093/infdis/jiad332.
2
T cell reactivity to Bordetella pertussis is highly diverse regardless of childhood vaccination.无论儿童时期是否接种过疫苗,对百日咳博德特氏菌的 T 细胞反应都具有高度多样性。
Cell Host Microbe. 2023 Aug 9;31(8):1404-1416.e4. doi: 10.1016/j.chom.2023.06.015. Epub 2023 Jul 24.
3
Multidisciplinary inpatient rehabilitation for older adults with COVID-19: a systematic review and meta-analysis of clinical and process outcomes.
废水监测作为疫情早期预警新型监测工具的潜力。
Emerg Microbes Infect. 2025 Dec;14(1):2528537. doi: 10.1080/22221751.2025.2528537. Epub 2025 Jul 10.
4
Resurgence of pertussis: Epidemiological trends, contributing factors, challenges, and recommendations for vaccination and surveillance.百日咳的死灰复燃:流行病学趋势、促成因素、挑战以及疫苗接种和监测建议。
Hum Vaccin Immunother. 2025 Dec;21(1):2513729. doi: 10.1080/21645515.2025.2513729. Epub 2025 Jun 9.
5
A budget impact analysis of adult immunization with tetanus, diphtheria, and pertussis vaccination for the prevention of pertussis in at-risk populations in Colombia.在哥伦比亚高危人群中使用破伤风、白喉和百日咳疫苗进行成人免疫以预防百日咳的预算影响分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2507885. doi: 10.1080/21645515.2025.2507885. Epub 2025 Jun 5.
6
Antibody signatures elicited by potent and subpotent whole-cell pertussis vaccines in mice.强效和低效全细胞百日咳疫苗在小鼠体内引发的抗体特征
Microbiol Spectr. 2025 Mar 25;13(5):e0325324. doi: 10.1128/spectrum.03253-24.
7
Pertussis Vaccination for Adults: An Updated Guide for Clinicians.成人百日咳疫苗接种:临床医生最新指南
Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060.
8
Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions.在疫苗接种和感染期间对百日咳博德特氏菌的适应性免疫反应:新出现的观点和未解决的问题。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):705-714. doi: 10.1080/14760584.2024.2383745. Epub 2024 Jul 24.
多学科住院康复治疗 COVID-19 老年患者:临床和治疗过程结局的系统评价和荟萃分析。
BMC Geriatr. 2023 Jun 27;23(1):391. doi: 10.1186/s12877-023-04098-4.
4
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces nasal colonization.系统预刺激和鼻内加强免疫 BcfA 佐剂无细胞百日咳疫苗可产生 CD4+IL-17+鼻组织固有 T 细胞,并减少鼻定植。
Front Immunol. 2023 May 18;14:1181876. doi: 10.3389/fimmu.2023.1181876. eCollection 2023.
5
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.BPZE1 鼻内减毒活百日咳疫苗的免疫原性和安全性与破伤风-白喉-无细胞百日咳疫苗的比较:一项随机、双盲、2b 期临床试验。
Lancet. 2023 Mar 11;401(10379):843-855. doi: 10.1016/S0140-6736(22)02644-7.
6
Assessment of Pertussis Underreporting in Italy.意大利百日咳漏报情况评估。
J Clin Med. 2023 Feb 21;12(5):1732. doi: 10.3390/jcm12051732.
7
Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity.在长期群体免疫背景下对全细胞百日咳疫苗和无细胞百日咳疫苗的评估。
Vaccines (Basel). 2022 Dec 20;11(1):1. doi: 10.3390/vaccines11010001.
8
Incidence of Respiratory Syncytial Virus Infection in Older Adults Before and During the COVID-19 Pandemic.老年人在 COVID-19 大流行前后感染呼吸道合胞病毒的情况。
JAMA Netw Open. 2023 Jan 3;6(1):e2250634. doi: 10.1001/jamanetworkopen.2022.50634.
9
Long-Term Effects of Hospitalization for COVID-19 on Frailty and Quality of Life in Older Adults ≥80 Years.新型冠状病毒肺炎住院治疗对80岁及以上老年人虚弱状态和生活质量的长期影响
J Clin Med. 2022 Sep 29;11(19):5787. doi: 10.3390/jcm11195787.
10
Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.美国高危成年人群的疫苗接种率和疫苗接种障碍。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2055422. doi: 10.1080/21645515.2022.2055422. Epub 2022 May 10.